Data / Form D filings / AKORN INC
AKORN INC: Form D filings
AKORN INC, a pharmaceuticals company in Lake Forest, IL, filed 2 Form D notices with the SEC in 2009. The latest, on April 29, 2009, reports an offering of $2.2 million with nothing sold yet to 1 investor.
Find out what AKORN INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1925 W. FIELD COURT, SUITE 300, Lake Forest, IL, 60045
- Phone
- (847) 279-6100
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- La
- Revenue range
- $25,000,001 - $100,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 3116
The full lists. Form D filings in Illinois: 1,511 rows, $75.55, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 29, 2009 | New notice | $2,152,999 | $0 | $2,152,999 | 1 | Apr 13, 2009 | sec.gov |
| Apr 29, 2009 | New notice | $1,667,145 | $0 | $1,667,145 | 1 | Apr 15, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jeffrey A. Whitnell | Executive Officer | |
| Subhash Kapre | Director | |
| Jerry I. Treppel | Director | |
| Neill Shanahan | Executive Officer | |
| Jerry N. Ellis | Director | |
| John R. Sabat | Executive Officer | |
| Michael P. Stehn | Executive Officer | |
| Ronald M. Johnson | Director | |
| Mark Silverberg | Executive Officer | |
| Randall Wall | Director | |
| Abu, Ph.D Alam | Executive Officer | |
| Sam, Ph.D Boddapati | Executive Officer |
Every Form D from the week of Apr 27, 2009 · All recent filings in Illinois · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what AKORN INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.